For those aiming to surpass market returns, the art of stock picking is crucial. Making wise choices in stocks can greatly enhance your overall wealth.
The price of Lexicon Pharmaceuticals Inc (NASDAQ: LXRX) closed at $0.70 in the last session, down -1.10% from day before closing price of $0.71. In other words, the price has decreased by -$1.10 from its previous closing price. On the day, 2.92 million shares were traded.
Ratios:
We take a closer look at LXRX’s different ratios to gain a better understanding of the stock. For the most recent quarter (mrq), Quick Ratio is recorded 7.43 and its Current Ratio is at 7.45. In the meantime, Its Debt-to-Equity ratio is 0.59 whereas as Long-Term Debt/Eq ratio is at 0.59.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, H.C. Wainwright on June 17, 2024, initiated with a Buy rating and assigned the stock a target price of $10.
On April 30, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $5.
On March 07, 2023, Jefferies started tracking the stock assigning a Hold rating and target price of $3.Jefferies initiated its Hold rating on March 07, 2023, with a $3 target price.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Aug 15 ’24 when COATS LONNEL bought 300,000 shares for $1.60 per share.
Valuation Measures:
For the stock, the TTM Price-to-Sale (P/S) ratio is 48.54 while its Price-to-Book (P/B) ratio in mrq is 1.42.
Stock Price History:
Over the past 52 weeks, LXRX has reached a high of $2.83, while it has fallen to a 52-week low of $0.62. The 50-Day Moving Average of the stock is -9.58%, while the 200-Day Moving Average is calculated to be -50.68%.
Shares Statistics:
A total of 361.49M shares are outstanding, with a floating share count of 179.90M. Insiders hold about 50.24% of the company’s shares, while institutions hold 35.20% stake in the company.
